Inventor · disambiguated record
Xianfeng Lin
Also filed as: LIN XIANFENG
14 granted patents·15 pending applications·91 citations·filing 2001–2025
90Inventor score
Files withHOFFMANN LA ROCHE20UNIV ZHEJIANG3SIR RUN RUN SHAW HOSPITAL ZHEJIANG UNIV SCHOOL OF MEDICINE2AGILTRON INC1CHEN LI1
Top patents by PatentIndex Score
29 records- 0194US9447086B26-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2013·Granted Sep 20, 2016·34 cites·5 claims
- 0293US9233978B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Jan 12, 2016·18 cites·23 claims
- 0390US10081627B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Sep 25, 2018·9 cites·30 claims
- 0489US10428069B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Oct 1, 2019·6 cites·21 claims
- 0580US9266904B26-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2014·Granted Feb 23, 2016·5 cites·23 claims
- 0679US9758530B26-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Sep 12, 2017·3 cites·14 claims
- 0774US12351575B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2019·Granted Jul 8, 2025·0 cites·13 claims
- 0872US6718082B2Solid-State optical wavelength switchesAGILTRON INC·Filed 2001·Granted Apr 6, 2004·15 cites·22 claims
- 0968US2025179096A1Oxidation-responsive water-soluble cationic pillararene, and preparation method and application thereofUNIV ZHEJIANG·Filed 2024·Application pending·0 cites
- 1064US2023286927A12-phenylbenzotriazol-5-amine derivatives for the treatment and prophylaxis of hepatitis b virus (hbv) infectionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1164US2023286968A1Aryloxazolo spiral ring derivatives for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1264US2023312491A1N-substituted 4-(5-phenyl-1,3,4-oxadiazol-2-yl)aniline for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1364US2023286930A1N -substituted 4-(1,3-aryloxazolo-2-yl)phenyl compounds for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1464US2023286969A1Aromatic spiro ring amide derivatives for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1564US2023416238A1N-[(1,3-benzoxazol-2-yl)-heterocycle]amide derivatives for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1663US2023331715A1Spiro[3.3]heptane derivatives for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1761US2024050577A1Cdk inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 1858US8404738B24-amino-N-hydroxy-benzamides for the treatment of cancerLIN XIANFENG·Filed 2012·Granted Mar 26, 2013·1 cites·21 claims
- 1956US2020339603A1Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2053US2013267517A1Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2152US10683299B2Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2019·Granted Jun 16, 2020·0 cites·12 claims
- 2252US2025230401A1Cell membrane-based biological material for cross-species cell component delivery and preparation method thereofUNIV ZHEJIANG·Filed 2025·Application pending·0 cites
- 2351US9856247B24-methyl-dihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Jan 2, 2018·0 cites·18 claims
- 2449US10662203B2Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2018·Granted May 26, 2020·0 cites·27 claims
- 2549US2025228787A1Biological material for delivering specific cell-targeted metabolic system, preparation method therefor, and application thereofUNIV ZHEJIANG·Filed 2025·Application pending·0 cites
- 2644US10597380B2Pyridazinone-based broad spectrum anti-influenza inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Mar 24, 2020·0 cites·42 claims
- 2736US2011195979A1Compounds for the treatment and prevention of influenzaCHEN LI·Filed 2011·Application pending·0 cites
- 2835US2022313609A1Nano composite material aiming at acidic sealing zone in osteoclasts and preparation method thereofSIR RUN RUN SHAW HOSPITAL ZHEJIANG UNIV SCHOOL OF MEDICINE·Filed 2020·Application pending·0 cites
- 2932US11684696B2Preparation method of gradient mineralized cancellous bone matrix materialSIR RUN RUN SHAW HOSPITAL ZHEJIANG UNIV SCHOOL OF MEDICINE·Filed 2019·Granted Jun 27, 2023·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Xianfeng Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →